GB0107907D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0107907D0
GB0107907D0 GBGB0107907.8A GB0107907A GB0107907D0 GB 0107907 D0 GB0107907 D0 GB 0107907D0 GB 0107907 A GB0107907 A GB 0107907A GB 0107907 D0 GB0107907 D0 GB 0107907D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0107907.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB0107907.8A priority Critical patent/GB0107907D0/en
Publication of GB0107907D0 publication Critical patent/GB0107907D0/en
Priority to PCT/EP2002/003572 priority patent/WO2002079190A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
GBGB0107907.8A 2001-03-29 2001-03-29 Novel compounds Ceased GB0107907D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0107907.8A GB0107907D0 (en) 2001-03-29 2001-03-29 Novel compounds
PCT/EP2002/003572 WO2002079190A1 (en) 2001-03-29 2002-03-28 3-substituted indoles as chemokine antagonists

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0107907.8A GB0107907D0 (en) 2001-03-29 2001-03-29 Novel compounds

Publications (1)

Publication Number Publication Date
GB0107907D0 true GB0107907D0 (en) 2001-05-23

Family

ID=9911854

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0107907.8A Ceased GB0107907D0 (en) 2001-03-29 2001-03-29 Novel compounds

Country Status (2)

Country Link
GB (1) GB0107907D0 (en)
WO (1) WO2002079190A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1604982A1 (en) 2001-07-02 2005-12-14 AstraZeneca AB Intermediates for the preparation of piperidine derivatives useful as modulators of chemokine receptor activity
GB0120461D0 (en) 2001-08-22 2001-10-17 Astrazeneca Ab Novel compounds
GB0122503D0 (en) 2001-09-18 2001-11-07 Astrazeneca Ab Chemical compounds
SE0200844D0 (en) 2002-03-19 2002-03-19 Astrazeneca Ab Chemical compounds
SE0200843D0 (en) 2002-03-19 2002-03-19 Astrazeneca Ab Chemical compounds
BR0317230A (en) * 2002-12-13 2005-10-25 Smithkline Beecham Corp Compound, composition, methods of antagonizing a ccr-5 chemokine receptor activity, and treating a viral infection in a patient, and use of a compound
WO2004069828A1 (en) * 2003-02-04 2004-08-19 Mitsubishi Pharma Corporation Piperidine compound and medicinal use thereof
SE0300850D0 (en) * 2003-03-25 2003-03-25 Astrazeneca Ab Chemical compounds
SE0300957D0 (en) 2003-04-01 2003-04-01 Astrazeneca Ab Chemical compounds
DE10337184A1 (en) 2003-08-13 2005-03-10 Gruenenthal Gmbh Substituted 3-pyrrolidine-indole derivatives
EP1802602A1 (en) * 2004-09-28 2007-07-04 Janssen Pharmaceutica N.V. Substituted dipiperdine ccr2 antagonists
ATE531706T1 (en) * 2005-04-30 2011-11-15 Boehringer Ingelheim Int NEW PIPERIDINE-SUBSTITUTED INDOLES AND THEIR USE AS CCR-3 MODULATORS
AU2006270548A1 (en) 2005-07-21 2007-01-25 Astrazeneca Ab Novel piperidine derivatives
US20070197590A1 (en) * 2006-01-31 2007-08-23 Demong Duane E Substituted dipiperidine ccr2 antagonists
CL2008001810A1 (en) * 2007-06-20 2008-12-26 Glaxo Group Ltd Compounds derived from spiroindolines, chemokine receptor modulators; pharmaceutical composition comprising said compounds; and its use to treat atherosclerosis, inflammatory pain, influenza, metabolic syndrome, among other diseases.
WO2010080873A1 (en) * 2009-01-08 2010-07-15 Glaxo Group Limited Oxazoles as modulators of chemokine receptors
MX2011010203A (en) 2009-04-02 2011-10-14 Merck Patent Gmbh Piperidine and piperazine derivatives as autotaxin inhibitors.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6184235B1 (en) * 1996-08-14 2001-02-06 Warner-Lambert Company 2-phenyl benzimidazole derivatives as MCP-1 antagonists
US6362201B1 (en) * 1999-03-02 2002-03-26 Merck & Co., Inc. 3-cyclopropyl and 3-cyclobutyl pyrrolidine modulators of chemokine receptor activity

Also Published As

Publication number Publication date
WO2002079190A1 (en) 2002-10-10

Similar Documents

Publication Publication Date Title
GB0105895D0 (en) Novel compounds
AU2002359165A8 (en) Novel compounds
GB0107907D0 (en) Novel compounds
GB0106586D0 (en) Novel compounds
GB0104259D0 (en) Novel compounds
GB0103866D0 (en) Novel compounds
GB0102470D0 (en) Novel compounds
GB0102713D0 (en) Novel compounds
GB0102578D0 (en) Novel Compounds
GB0107631D0 (en) Novel compounds
GB0100181D0 (en) Novel compounds
GB0106613D0 (en) Novel compounds
GB0100182D0 (en) Novel compounds
GB0100184D0 (en) Novel compounds
GB0100185D0 (en) Novel compounds
GB0100186D0 (en) Novel compounds
GB0100187D0 (en) Novel compounds
GB0101334D0 (en) Novel compounds
GB0101437D0 (en) Novel Compounds
GB0102469D0 (en) Novel compounds
GB0102570D0 (en) Novel Compounds
GB0102575D0 (en) Novel Compounds
GB0102576D0 (en) Novel compounds
GB0102577D0 (en) Novel Compounds
GB0100179D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)